Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential
NCT ID: NCT02183285
Last Updated: 2014-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
203 participants
INTERVENTIONAL
2003-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Everyday Functioning in Adults Aged 70 and Over Using a Multivitamin Supplement
NCT04112732
Influences of Multivitamin Supplementation on Health Parameters
NCT03071796
Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia
NCT02343497
Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia
NCT04861376
Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement
NCT05646368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PHL 00747 capsules
Pharmaton PHL 00747 soft gelatine capsules
Placebo film-coated tablets (fct)
PHL 00747 tablets
Pharmaton PHL 00747 film-coated tablets
Placebo soft gelatine capsules
Placebo
Placebo film-coated tablets (fct)
Placebo soft gelatine capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmaton PHL 00747 soft gelatine capsules
Pharmaton PHL 00747 film-coated tablets
Placebo film-coated tablets (fct)
Placebo soft gelatine capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages ranging between 18 and 40 years
* Willing and able to give written informed consent in accordance to Good Clinical Practice (GCP) and local legislation prior to participation in the study
Exclusion Criteria
* Known hypersensitivity to any of the ingredients
* Alcohol- or drug-addiction
* Currently participation in another trial, or has participated in a trial within the previous 30 days
* Known abnormal values of the laboratory tests (if detected after enrolment, subjects will continue the treatment provided there are no medical objections)
* Already taking other mult-vitamin products during the last 2 weeks
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1209.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.